Discovery of IHMT-MST1-58 as a Novel, Potent, and Selective MST1 Inhibitor for the Treatment of Type 1/2 Diabetes-Reference-Cited by-同舟云学术

Discovery of IHMT-MST1-58 as a Novel, Potent, and Selective MST1 Inhibitor for the Treatment of Type 1/2 Diabetes

Published:2022-08-29 Issue:17 Volume:65 Page:11818-11839
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Wu Yun¹²,Qi Ziping¹²,Wang Beilei¹²,Wang Junjie¹³,Liu Qingwang¹²,Wang Aoli¹²,Shi Chenliang¹³,Zhou Bin¹³,Liang Qianmao¹³,Wang Wenliang¹⁴,Zou Fengming¹²,Qi Shuang¹²,Wang Zuowei¹³,Wang Li¹²,Wang Wenchao¹²³,Liu Jing¹²³^ORCID,Liu Qingsong¹²³⁴^ORCID

Affiliation:

1. Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui 230031, P. R. China

2. Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, Anhui 230031, P. R. China

3. University of Science and Technology of China, Hefei, Anhui 230026, P. R. China

4. Precision Medicine Research Laboratory of Anhui Province, Hefei, Anhui 230088, P. R. China

Funder

Hefei Institutes of Physical Science, Chinese Academy of Sciences

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Natural Science Foundation of Anhui Province

Chinese Academy of Sciences

Plan for Major Anhui Provincial Science and Technology Project

Publisher

American Chemical Society (ACS)